FR Appelbaum, J Barrall, R Storb, LD Fisher … - Annals of Internal …, 1990 - Am Coll Physicians Study Objective: To determine the efficacy of allogeneic bone marrow transplantation for severe
myelodysplasia, and to identify variables predictive of outcome. ... Setting: A referral-based bone
marrow transplant center. ... Patients: Consecutive series of 59 patients with ... Cited by 102 - Related articles - All 3 versions
T De Witte, F Zwaan, J Hermans, J Vernant, H … - British journal of …, 1990 - ncbi.nlm.nih.gov This retrospective survey of the EBMT Leukaemia Working Party describes 78 patients with myelodysplasia
(MDS) or secondary acute myelogenous leukaemia (sAML) who received an allogeneic bone
marrow transplant (BMT). The status of underlying disease at the time of transplantation ... Cited by 124 - Related articles
- ►ascopubs.org [PDF] G Longmore, EC Guinan, HJ Weinstein, RD … - Journal of Clinical …, 1990 - jco.ascopubs.org Bone Marrow Transplantation for Myelodysplasia and Secondary Acute Nonlymphoblastic Leukemia ... By Gregory Longmore, Eva C. Guinan, Howard J. Weinstein, Richard D. Gelber, Joel M.
Rappeport, and Joseph H. Antin ... Twenty-three patients with primary myelodysplasia ... Cited by 78 - Related articles - All 6 versions
- ►ascopubs.org [PDF] MR O'donnell, AP Nademanee, DS Snyder, … - Journal of Clinical …, 1987 - jco.ascopubs.org Twenty patients (age range, 4 to 48 years; median age, 36 years) with de novo or drug-induced
myelo- dysplastic syndromes or myeloproliferative disorders were treated with myeloablative
immunosuppressive therapy followed by bone marrow transplantation (BMT). Four ... Cited by 70 - Related articles - All 5 versions
- ►hematologylibrary.org [PDF] JE Anderson, FR Appelbaum, LD Fisher, G … - …, 1993 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of Suite 200, Washington
DC 20036. semimonthly by the American Society of Hematology, 1900 M St, NW, Blood (print
ISSN 0006-4971, online ISSN 1528-0020), is published ... For personal use only. at ... Cited by 185 - Related articles - BL Direct - All 7 versions
- ►hematologylibrary.org [PDF] JE Anderson, FR Appelbaum, G Schoch, T … - …, 1996 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of Suite 200, Washington
DC 20036. semimonthly by the American Society of Hematology, 1900 M St, NW, Blood (print
ISSN 0006-4971, online ISSN 1528-0020), is published ... For personal use only. at ... Cited by 93 - Related articles - BL Direct - All 5 versions
G Tricot, MA Boogaerts - Br J Haematol, 1986 - interscience.wiley.com Fifteen patients with the initial diagnosis of myelodysplastic syndrome (MDS) received aggressive
chemotherapy with high dose cytarabine or with a standard acute myeloid leukaemia (AML)
regime. Cases treated with aggressive chemotherapy were either younger individuals ... Cited by 92 - Related articles - All 3 versions
- ►ascopubs.org [PDF] MR O'donnell, GD Long, PM Parker, J Niland, … - Journal of Clinical …, 1995 - jco.ascopubs.org Purpose: A non-radiation-containing regimen of bu- sulfan and cyclophosphamide (BU/CY) was
evaluated for toxicity, relapse, and long-term survival in patients who received allogeneic bone
marrow transplantation (BMT) for myelodysplasia (MDS). Patients and Methods: ... Cited by 62 - Related articles - BL Direct - All 6 versions
T De Witte, P Muus, B De Pauw, C … - CA A Cancer Journal for … - interscience.wiley.com Intensive antileukemic treatment was evaluated in 22 patients with secondary acute myelogenous
leukemia (sAML) and 14 patients with myelodysplastic syndrome (MDS). Results of combination
remission-induction chemotherapy were compared with 126 patients contemporarily ... Cited by 76 - Related articles - All 2 versions
JE Anderson, C Anasetti, FR Appelbaum, … - British Journal of …, 1996 - interscience.wiley.com Allogeneic marrow transplantation using related marrow donors for myelodysplasia (MDS) and
acute myeloid leukaemia (AML) arising from MDS results in 35–56% actuarial disease-free
survival. Because the use of unrelated donors has not been well-characterized, we report ... Cited by 103 - Related articles - BL Direct - All 4 versions
